Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pryde, P. G.
Right arrow Articles by Barr, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pryde, P. G.
Right arrow Articles by Barr, M., Jr

Journal of the American Society of Nephrology, Vol 3, 1575-1582, Copyright © 1993 by American Society of Nephrology


REGULAR ARTICLES

Angiotensin-converting enzyme inhibitor fetopathy

PG Pryde, AB Sedman, CE Nugent and M Barr Jr
Department of Obstetrics/Gynecology, University of Michigan Medical Center, Ann Arbor.

Angiotensin-converting enzyme (ACE) inhibitors are widely used for controlling hypertension. Their use in women who are pregnant is not without risk to the fetus. We describe three infants exposed in utero to ACE inhibitors who had adverse outcomes. These cases, combined with other reports in the literature, suggest strongly that these drugs are fetotoxic. ACE inhibitor fetopathy is characterized by fetal hypotension, anuria-oligohydramnios, growth restriction, pulmonary hypoplasia, renal tubular dysplasia, and hypocalvaria. Although the true frequency of adverse fetal effects has yet to be determined, because of the debilitating and lethal nature of the fetal damage when it occurs, it is our recommendation that ACE inhibitors not be used in pregnancy, particularly in the second and third trimesters.


This article has been cited by other articles:


Home page
HypertensionHome page
T. Podymow and P. August
Update on the Use of Antihypertensive Drugs in Pregnancy
Hypertension, April 1, 2008; 51(4): 960 - 969.
[Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
H. Kobori, M. Nangaku, L. G. Navar, and A. Nishiyama
The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease
Pharmacol. Rev., September 1, 2007; 59(3): 251 - 287.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
C. O. Chen, M. H. Park, M. S. Forbes, B. A. Thornhill, S. C. Kiley, K. H. Yoo, and R. L. Chevalier
Angiotensin-converting enzyme inhibition aggravates renal interstitial injury resulting from partial unilateral ureteral obstruction in the neonatal rat
Am J Physiol Renal Physiol, March 1, 2007; 292(3): F946 - F955.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. F. Schreuder, J. R. Nyengaard, F. Remmers, J. A. van Wijk, and H. A. Delemarre-van de Waal
Postnatal food restriction in the rat as a model for a low nephron endowment
Am J Physiol Renal Physiol, November 1, 2006; 291(5): F1104 - F1107.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Lacoste, Y. Cai, L. Guicharnaud, F. Mounier, Y. Dumez, R. Bouvier, F. Dijoud, M. Gonzales, J. Chatten, A.-L. Delezoide, et al.
Renal Tubular Dysgenesis, a Not Uncommon Autosomal Recessive Disorder Leading to Oligohydramnios: Role of the Renin-Angiotensin System
J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2253 - 2263.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
D. Lasaitiene, Y. Chen, V. Mildaziene, Z. Nauciene, B. Sundelin, B. R. Johansson, M. Yano, and P. Friberg
Tubular mitochondrial alterations in neonatal rats subjected to RAS inhibition
Am J Physiol Renal Physiol, May 1, 2006; 290(5): F1260 - F1269.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. Chen, L. C. Carey, J. Liu, N. K. Valego, S. B. Tatter, and J. C. Rose
The effect of hypothalamo-pituitary disconnection on the renin-angiotensin system in the late-gestation fetal sheep
Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2005; 288(5): R1279 - R1287.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S.-L. Zhang, B. Moini, and J. R. Ingelfinger
Angiotensin II Increases Pax-2 Expression in Fetal Kidney Cells Via the AT2 Receptor
J. Am. Soc. Nephrol., June 1, 2004; 15(6): 1452 - 1465.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
M.-G. Mercado-Deane, J. E. Beeson, and S. D. John
US of Renal Insufficiency in Neonates
RadioGraphics, November 1, 2002; 22(6): 1429 - 1438.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Lessan-Pezeshki
Pregnancy after renal transplantation: points to consider
Nephrol. Dial. Transplant., May 1, 2002; 17(5): 703 - 707.
[Full Text] [PDF]


Home page
Cold Spring Harb Symp Quant BiolHome page
S.B. GURLEY, T.H. LE, and T.M. COFFMAN
Gene-targeting Studies of the Renin-Angiotensin System: Mechanisms of Hypertension and Cardiovascular Disease
Cold Spring Harb Symp Quant Biol, January 1, 2002; 67(0): 451 - 458.
[Abstract] [PDF]


Home page
Obstet GynecolHome page
P. G. Pryde, M. Barr Jr, and T. R. Easterling
LOW-DOSE, SHORT-ACTING,ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AS RESCUE THERAPY IN PREGNANCY
Obstet. Gynecol., May 1, 2001; 97(5): 799 - 800.
[Full Text] [PDF]


Home page
Obstet GynecolHome page
R. L. Ferrer, B. M. Sibai, C. D. Mulrow, E. Chiquette, K. R. Stevens, and J. Cornell
MANAGEMENT OF MILD CHRONIC HYPERTENSION DURING PREGNANCY: A REVIEW
Obstet. Gynecol., November 1, 2000; 96(5): 849 - 860.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. Moritz, I. Koukoulas, A. Albiston, and E. M. Wintour
Angiotensin II infusion to the midgestation ovine fetus: effects on the fetal kidney
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2000; 279(4): R1290 - R1297.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
R. J. Hogg, R. J. Portman, D. Milliner, K. V. Lemley, A. Eddy, and J. Ingelfinger
Evaluation and Management of Proteinuria and Nephrotic Syndrome in Children: Recommendations From a Pediatric Nephrology Panel Established at the National Kidney Foundation Conference on Proteinuria, Albuminuria, Risk, Assessment, Detection, and Elimination (PARADE)
Pediatrics, June 1, 2000; 105(6): 1242 - 1249.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
D. Mahieu-Caputo, M. Dommergues, A.-L. Delezoide, M. Lacoste, Y. Cai, F. Narcy, D. Jolly, M. Gonzales, Y. Dumez, and M.-C. Gubler
Twin-to-Twin Transfusion Syndrome : Role of the Fetal Renin-Angiotensin System
Am. J. Pathol., February 1, 2000; 156(2): 629 - 636.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. GURON, N. MARCUSSEN, A. NILSSON, B. SUNDELIN, and P. FRIBERG
Postnatal Time Frame for Renal Vulnerability to Enalapril in Rats
J. Am. Soc. Nephrol., July 1, 1999; 10(7): 1550 - 1560.
[Abstract] [Full Text]


Home page
CLIN PEDIATRHome page
U. S. Alon
Neonatal Acute Renal Failure: The Need for Long-Term Follow-up
Clinical Pediatrics, June 1, 1998; 37(6): 387 - 389.
[PDF]


Home page
CirculationHome page
N. J. Brown and D. E. Vaughan
Angiotensin-Converting Enzyme Inhibitors
Circulation, April 14, 1998; 97(14): 1411 - 1420.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. Guron, A. Nilsson, G. F. Dibona, B. Sundelin, N. Nitescu, and P. Friberg
Renal adaptation to dietary sodium restriction and loading in rats treated neonatally with enalapril
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1997; 273(4): R1421 - R1429.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
F. G. Smith, S. Chan, and S. N. De Wildt
Effects of renal denervation on cardiovascular and renal responses to ACE inhibition in conscious lambs
J Appl Physiol, August 1, 1997; 83(2): 414 - 419.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. F. Hilgers, V. Reddi, J. H. Krege, O. Smithies, and R. A. Gomez
Aberrant Renal Vascular Morphology and Renin Expression in Mutant Mice Lacking Angiotensin-Converting Enzyme
Hypertension, January 1, 1997; 29(1): 216 - 221.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP